BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29749251)

  • 1. Prucalopride in clozapine-induced constipation.
    Thomas N; Jain N; Connally F; Yeung JM; Pantelis C
    Aust N Z J Psychiatry; 2018 Aug; 52(8):804. PubMed ID: 29749251
    [No Abstract]   [Full Text] [Related]  

  • 2. Prucalopride in a case of severe opioid induced constipation.
    Dagtekin O
    Minerva Anestesiol; 2012 Apr; 78(4):513-4. PubMed ID: 22310195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the efficacy of prucalopride (resolor) in the treatment of patients with chronic constipation].
    Osipenko MF; Bikbulatova EA; Skalinskaia MA; Kulygina IuA; Pankova LIu
    Ter Arkh; 2013; 85(12):60-4. PubMed ID: 24640670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-threatening constipation associated with clozapine.
    Rege S; Lafferty T
    Australas Psychiatry; 2008 Jun; 16(3):216-9. PubMed ID: 18568631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prucalopride - oral (Resolor)].
    J Pharm Belg; 2010 Dec; (4):133-4. PubMed ID: 21294319
    [No Abstract]   [Full Text] [Related]  

  • 6. Prucalopride for constipation.
    Camilleri M; Deiteren A
    Expert Opin Pharmacother; 2010 Feb; 11(3):451-61. PubMed ID: 20102308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of clozapine-induced constipation with bethanechol.
    Poetter CE; Stewart JT
    J Clin Psychopharmacol; 2013 Oct; 33(5):713-4. PubMed ID: 23963061
    [No Abstract]   [Full Text] [Related]  

  • 8. Prucalopride succinate for the treatment of constipation: an update.
    Bassotti G; Gambaccini D; Bellini M
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians.
    Morais SA; Ford AC
    Neurogastroenterol Motil; 2013 Jan; 25(1):89. PubMed ID: 23279729
    [No Abstract]   [Full Text] [Related]  

  • 10. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
    Pennant M; Orlando R; Barton P; Bayliss S; Routh K; Meads C
    Health Technol Assess; 2011 May; 15 Suppl 1():43-50. PubMed ID: 21609652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.
    Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ
    Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
    Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
    Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prucalopride: For functional constipation only?
    Bellini M; Gambaccini D; Bassotti G
    Tech Coloproctol; 2016 Jul; 20(7):433-6. PubMed ID: 27174045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prucalopride: a new drug for the treatment of chronic constipation.
    Tack J
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of Resolor (prucalopride) for chronic constipation in women.
    Woodward S
    Br J Nurs; 2012 Sep 13-26; 21(16):982, 984-6. PubMed ID: 23123655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prucalopride. In chronic constipation: poorly documented risks.
    Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP
    Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation.
    Müller-Lissner S; Rykx A; Kerstens R; Vandeplassche L
    Neurogastroenterol Motil; 2010 Sep; 22(9):991-8, e255. PubMed ID: 20529205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
    Tack J; Corsetti M
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of prucalopride in adults with chronic idiopathic constipation.
    Vijayvargiya P; Camilleri M
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.